Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

DNA methylation and cancer.

Das PM, Singal R.

J Clin Oncol. 2004 Nov 15;22(22):4632-42. Review.

PMID:
15542813
2.

DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias.

Leone G, Teofili L, Voso MT, Lübbert M.

Haematologica. 2002 Dec;87(12):1324-41. Review.

3.

The role of DNA methylation in cancer development.

Luczak MW, Jagodziński PP.

Folia Histochem Cytobiol. 2006;44(3):143-54. Review.

4.

Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.

Sigalotti L, Fratta E, Coral S, Cortini E, Covre A, Nicolay HJ, Anzalone L, Pezzani L, Di Giacomo AM, Fonsatti E, Colizzi F, Altomonte M, Calabrò L, Maio M.

J Cell Physiol. 2007 Aug;212(2):330-44. Review.

PMID:
17458893
5.

DNA methylation disturbances as novel therapeutic target in lung cancer: preclinical and clinical results.

Digel W, Lübbert M.

Crit Rev Oncol Hematol. 2005 Jul;55(1):1-11. Review.

PMID:
15886007
6.
7.

Epigenome: a new target in cancer therapy.

Giacinti L, Vici P, Lopez M.

Clin Ter. 2008 Sep-Oct;159(5):347-60. Review.

PMID:
18998037
8.

Epigenetic alterations and cancer: new targets for therapy.

Allen A.

IDrugs. 2007 Oct;10(10):709-12. Review.

PMID:
17899489
9.

[Epigenome and cancer: new possibilities of cancer prevention and therapy?].

Paluszczak J, Baer-Dubowska W.

Postepy Biochem. 2005;51(3):244-50. Review. Polish.

PMID:
16381168
10.

DNA demethylating agents and epigenetic therapy of cancer.

Mani S, Herceg Z.

Adv Genet. 2010;70:327-40. doi: 10.1016/B978-0-12-380866-0.60012-5. Review.

PMID:
20920754
11.

DNA methylation and cancer therapy: new developments and expectations.

Esteller M.

Curr Opin Oncol. 2005 Jan;17(1):55-60. Review.

PMID:
15608514
12.

DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment.

Barton CA, Hacker NF, Clark SJ, O'Brien PM.

Gynecol Oncol. 2008 Apr;109(1):129-39. doi: 10.1016/j.ygyno.2007.12.017. Epub 2008 Jan 29. Review.

PMID:
18234305
13.

[DNA methylation: an epigenetic mechanism for tumorigenesis].

Zhang LL, Wu JX.

Yi Chuan. 2006 Jul;28(7):880-5. Review. Chinese.

PMID:
16825178
14.

Epigenetic changes in solid and hematopoietic tumors.

Toyota M, Issa JP.

Semin Oncol. 2005 Oct;32(5):521-30. Review.

PMID:
16210093
15.

[Contribution of molecular biology to new diagnostic and/or prognostic markers characterization in cancerogenesis].

de Fraipont F.

Ann Biol Clin (Paris). 2007 Jan-Feb;65(1):21-6. Review. French.

PMID:
17264035
16.

New therapeutic targets in cancer: the epigenetic connection.

Herranz M, Esteller M.

Clin Transl Oncol. 2006 Apr;8(4):242-9. Review.

PMID:
16648099
17.

DNA demethylation and carcinogenesis.

Kisseljova NP, Kisseljov FL.

Biochemistry (Mosc). 2005 Jul;70(7):743-52. Review.

18.

Cancer-linked DNA hypomethylation and its relationship to hypermethylation.

Ehrlich M.

Curr Top Microbiol Immunol. 2006;310:251-74. Review.

PMID:
16909914
19.

Genome-wide hypomethylation in cancer may be a passive consequence of transformation.

Wild L, Flanagan JM.

Biochim Biophys Acta. 2010 Aug;1806(1):50-7. doi: 10.1016/j.bbcan.2010.03.003. Epub 2010 Apr 14. Review.

PMID:
20398739
20.

Epigenetic changes in cancer.

Grønbaek K, Hother C, Jones PA.

APMIS. 2007 Oct;115(10):1039-59. Review.

PMID:
18042143
Items per page

Supplemental Content

Write to the Help Desk